Eargo specialises in developing hearing aid and related services. Eargo has four products in its lineup: namely, Eargo Max, Eargo Neo HiFi, Eargo 5 and Eargo 6. The company’s products are unique due to its design meant to keep the device invisible when plugged in.
The products are priced between USD 1,850 (Eargo Max) and USD 2,950 (Eargo 6) and as per the company, are around half of the price of the hearing aids provided via traditional channels in the US. The Eargo Neo range comes alongside an app and offers connected smart features such as audio personalization and control. The app allows the user to control the audio to suit their surroundings, customize settings, and contact Eargo's licensed hearing professionals for consultation and support.
The company utilizes a business-to-consumer (D2C) online retail strategy compared to traditional business-to-business (B2B) model deployed by other manufacturers who sell their products through clinics. The strategy has proven beneficial through the Covid-19 pandemic as consumer footfall for brick-and-mortar clinics have declined.
Funding and financials
The company last raised funds in November 2022 when Patient Square Capital became the majority owner of Eargo through a conversion of its convertible notes. The gross proceeds from the transaction raised USD 32.5 million for Eargo, including an investment of USD 5.5 million by Patient Square Capital and an expense of USD 2.5 million in transaction-related expenses. The raised funds were set aside for working capital purposes and to fund Eargo's omni-channel growth strategy.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.